These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 25485735)

  • 41. [Hepatitis B and C: natural course of disease].
    Vince A
    Acta Med Croatica; 2005; 59(5):389-92. PubMed ID: 16381232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.
    Kamal SM; Graham CS; He Q; Bianchi L; Tawil AA; Rasenack JW; Khalifa KA; Massoud MM; Koziel MJ
    J Infect Dis; 2004 Apr; 189(7):1140-50. PubMed ID: 15031780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patients.
    Labarga P; Fernandez-Montero JV; de Mendoza C; Barreiro P; Pinilla J; Soriano V
    Antivir Ther; 2015; 20(3):329-34. PubMed ID: 25372299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy.
    Pineda JA; García-García JA; Aguilar-Guisado M; Ríos-Villegas MJ; Ruiz-Morales J; Rivero A; del Valle J; Luque R; Rodríguez-Baño J; González-Serrano M; Camacho A; Macías J; Grilo I; Gómez-Mateos JM;
    Hepatology; 2007 Sep; 46(3):622-30. PubMed ID: 17659577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
    Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progression of fibrosis in chronic hepatitis C.
    Ghany MG; Kleiner DE; Alter H; Doo E; Khokar F; Promrat K; Herion D; Park Y; Liang TJ; Hoofnagle JH
    Gastroenterology; 2003 Jan; 124(1):97-104. PubMed ID: 12512034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contribution of obesity to hepatitis C-related fibrosis progression.
    Ortiz V; Berenguer M; Rayón JM; Carrasco D; Berenguer J
    Am J Gastroenterol; 2002 Sep; 97(9):2408-14. PubMed ID: 12358265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
    Poynard T; Bedossa P; Opolon P
    Lancet; 1997 Mar; 349(9055):825-32. PubMed ID: 9121257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation.
    Chopra KB; Demetris AJ; Blakolmer K; Dvorchik I; Laskus T; Wang LF; Araya VR; Dodson F; Fung JJ; Rakela J; Vargas HE
    Transplantation; 2003 Nov; 76(10):1487-91. PubMed ID: 14657691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neutralizing antibodies in patients with chronic hepatitis C and correlation to liver cirrhosis and estimated duration of infection.
    Pedersen J; Lundbo LF; Krarup H; Bukh J; Weis N
    J Med Virol; 2016 Oct; 88(10):1791-803. PubMed ID: 27027386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of chronic hepatitis C on HIV-1 disease progression.
    Carlos Martín J; Castilla J; López M; Arranz R; González-Lahoz J; Soriano V
    HIV Clin Trials; 2004; 5(3):125-31. PubMed ID: 15248136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J; Ryzlová M; Striteský J; Horák J
    Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center.
    Forns X; Ampurdanès S; Sanchez-Tapias JM; Guilera M; Sans M; Sánchez-Fueyo A; Quintó L; Joya P; Bruguera M; Rodés J
    J Hepatol; 2001 Aug; 35(2):265-71. PubMed ID: 11580150
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.
    Glässner A; Eisenhardt M; Kokordelis P; Krämer B; Wolter F; Nischalke HD; Boesecke C; Sauerbruch T; Rockstroh JK; Spengler U; Nattermann J
    J Hepatol; 2013 Sep; 59(3):427-33. PubMed ID: 23665286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis.
    García-García JA; Romero-Gómez M; Girón-González JA; Rivera-Irigoin R; Torre-Cisneros J; Montero JL; González-Serrano M; Andrade RJ; Aguilar-Guisado M; Grilo I; Martín-Vivaldi J; Salmerón J; Caballero-Granado FJ; Macías J; Vergara-López S; Pineda JA; ;
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1236-41. PubMed ID: 17209765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting progressive hepatic fibrosis stage on subsequent liver biopsy in chronic hepatitis C virus infection.
    Collier JD; Woodall T; Wight DG; Shore S; Gimson AE; Alexander GJ
    J Viral Hepat; 2005 Jan; 12(1):74-80. PubMed ID: 15655051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.
    Berenguer J; Zamora FX; Aldámiz-Echevarría T; Von Wichmann MA; Crespo M; López-Aldeguer J; Carrero A; Montes M; Quereda C; Téllez MJ; Galindo MJ; Sanz J; Santos I; Guardiola JM; Barros C; Ortega E; Pulido F; Rubio R; Mallolas J; Tural C; Jusdado JJ; Pérez G; Díez C; Álvarez-Pellicer J; Esteban H; Bellón JM; González-García J;
    Clin Infect Dis; 2015 Mar; 60(6):950-8. PubMed ID: 25422386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.